Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,243,574
-
Total 13F shares
-
1,362,190
-
Share change
-
+133,264
-
Total reported value
-
$8,426,122
-
Price per share
-
$6.19
-
Number of holders
-
21
-
Value change
-
+$1,144,778
-
Number of buys
-
7
-
Number of sells
-
8
Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock (TENX) as of Q4 2024
As of 31 Dec 2024,
TENAX THERAPEUTICS, INC. - Common Stock (TENX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,362,190 shares.
The largest 10 holders included
BVF INC/IL, Vivo Capital, LLC, VR Adviser, LLC, JANUS HENDERSON GROUP PLC, Velan Capital Investment Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, Vestal Point Capital, LP, ADAR1 Capital Management, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.